孟鲁司特钠治疗咳嗽变异性哮喘疗效观察被引量：2

下载PDF

导出

摘要目的观察孟鲁司特钠(顺尔宁)治疗咳嗽变异性哮喘的疗效。方法将100例咳嗽变异性哮喘患者随机分为2组:治疗组口服盐酸丙卡特罗(美普清)和孟鲁司特钠,对照组吸入布地奈德(普米克)及硫酸沙丁胺醇气雾剂。观察用药后1周1、5 d、1个月、3个月咳嗽消失情况。结果治疗组显效50例,有效4例,无效1例;对照组显效43例,有效2例,无效0例。2组疗效比较无显著性差异(P>0.05)。结论口服孟鲁司特钠与吸入布地奈德治疗咳嗽变异性哮喘效果相当,但孟鲁司特钠使用方便。

作者胡佩莉

机构地区浙江省宁波市镇海龙赛医院

出处《现代中西医结合杂志》 CAS 2008年第28期4400-4401,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine

关键词咳嗽变异性哮喘孟鲁司特钠布地奈德

分类号 R562.25 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献6

1沈瑶,金美玲,白春学.慢性咳嗽和白三烯受体拮抗剂[J].国际呼吸杂志,2007,27(7):528-530. 被引量：48
2Barmes NC, Smith LJ. Biochemistry and physiology of the leukotrienes [ J ]. Clin Rev Allergy Immunol, 1999,17:27 - 42
3曹卫军,李强,刘忠令.支气管哮喘的气道重构与药物治疗[J].国际呼吸杂志,2007,27(19):1486-1489. 被引量：10
4Bisgaard H, Nielsen KG. Bronchoprotection with aleukotriene receptor antagonist in asthmatic preschool children [ J ]. Am Rev Respir Critcare Med, 2000,162 : 187 - 190
5刘莹.顺尔宁[J].中国新药杂志,2001,10(2):136-137. 被引量：71
6Hans B,Kim G,Nielsen. Bronchoprotection with a leukotrienes recept or antagonist in asthmatic preschool children[J]. Am J Respis Crit Med, 2000,162 : 187 - 190

二级参考文献42

1Irwin RS,Madison JM. The diagnosis and treatment of cough. N Eng J Med,2000,343 : 1715-1721.
2Susan M. Harding chronic cough practical considerations. Chest,2003,123:659.
3Brightling CE,Ward R,Goh KL,et al. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med, 1999,160:406-410.
4Irwin RS, Madison JM. Anatomical diagnostic protocol in evaluating chronic cough with specific reference to gastroesophageal reflux disease. Am J Med, 2000, 108: 126s-130s.
5Ayik SO,Basoglu OK, Erdinc M,et al. Eosinophilic bronchitis as a cause of chronic cough. Respir Med, 2003,97 : 695-701.
6Irwin RS, Boult LP, Cloulies MM, et al. Managing cough as a defense mechanism and as a symptoms. Chest, 1998,114 : 133.
7Niimi A, Matsumoto H ,Minakuchi M, et al. Airway remodeling in cough-variant asthma. Lancet, 2000,356 : 564-565.
8Gibson PG, Fujimura M. Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax, 2002,57 :178-182.
9Van Schaik SM, Tristam DA, Nagpal IS, et al. Increased production of IFN-gamma and cysteinyl leukotrienes in virusinduced wheezing. J Allergy Clin Immunol, 1999,103 : 630-636.
10Bisgaard HA. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am Rev Respir Crit Care Med,2003,167:379-383.